Stifel Financial’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-16,512
| Closed | -$204K | – | 3582 |
|
|
2024
Q4 | $204K | Sell |
16,512
-380
| -2% | -$4.35K | ﹤0.01% | 3161 |
|
|
2024
Q3 | $192K | Hold |
16,892
| – | – | ﹤0.01% | 3150 |
|
|
2024
Q2 | $121K | Sell |
16,892
-2,473
| -13% | -$18.9K | ﹤0.01% | 3188 |
|
|
2024
Q1 | $130K | Sell |
19,365
-1,185
| -6% | -$8.15K | ﹤0.01% | 3158 |
|
|
2023
Q4 | $134K | Sell |
20,550
-5,150
| -20% | -$33.2K | ﹤0.01% | 3128 |
|
|
2023
Q3 | $243K | Buy |
25,700
+15,100
| +142% | +$182K | ﹤0.01% | 2899 |
|
|
2023
Q2 | $148K | Buy |
+10,600
| New | +$181K | ﹤0.01% | 3105 |
|
|
2019
Q4 | – | Sell |
-34,908
| Closed | -$170K | – | 3087 |
|
|
2019
Q3 | $170K | Sell |
34,908
-242
| -0.7% | -$1.5K | ﹤0.01% | 2685 |
|
|
2019
Q2 | $180K | Sell |
35,150
-998
| -3% | -$4.12K | ﹤0.01% | 2741 |
|
|
2019
Q1 | $139K | Sell |
36,148
-828
| -2% | -$3.38K | ﹤0.01% | 2652 |
|
|
2018
Q4 | $139K | Sell |
36,976
-143,243
| -79% | -$747K | ﹤0.01% | 2518 |
|
|
2018
Q3 | $1.24M | Sell |
180,219
-8,627
| -5% | -$51.1K | ﹤0.01% | 1549 |
|
|
2018
Q2 | $747K | Sell |
188,846
-1,749
| -0.9% | -$6.07K | ﹤0.01% | 1809 |
|
|
2018
Q1 | $555K | Sell |
190,595
-4,507
| -2% | -$13.9K | ﹤0.01% | 1913 |
|
|
2017
Q4 | $761K | Sell |
195,102
-9,203
| -5% | -$39.4K | ﹤0.01% | 1681 |
|
|
2017
Q3 | $640K | Buy |
204,305
+200,762
| +5,666% | +$754K | ﹤0.01% | 1743 |
|
|
2017
Q2 | $15K | Hold |
3,543
| – | – | ﹤0.01% | 2540 |
|
|
2017
Q1 | $16K | Buy |
3,543
+1,092
| +45% | +$3.66K | ﹤0.01% | 2510 |
|
|
2016
Q4 | $4K | Hold |
2,451
| – | – | ﹤0.01% | 2460 |
|
|
2016
Q3 | $7K | Hold |
2,451
| – | – | ﹤0.01% | 2379 |
|
|
2016
Q2 | $6K | Hold |
2,451
| – | – | ﹤0.01% | 2501 |
|
|
2016
Q1 | $7K | Sell |
2,451
-5,395
| -69% | -$28.9K | ﹤0.01% | 2225 |
|
|
2015
Q4 | $64K | Hold |
7,846
| – | – | ﹤0.01% | 2261 |
|
|
2015
Q3 | $56K | Buy |
7,846
+764
| +11% | +$6.38K | ﹤0.01% | 2176 |
|
|
2015
Q2 | $65K | Sell |
7,082
-41
| -0.6% | -$394 | ﹤0.01% | 2286 |
|
|
2015
Q1 | $67K | Sell |
7,123
-1,103
| -13% | -$10.6K | ﹤0.01% | 2222 |
|
|
2014
Q4 | $80K | Sell |
8,226
-211
| -3% | -$2.13K | ﹤0.01% | 2204 |
|
|
2014
Q3 | $80K | Hold |
8,437
| – | – | ﹤0.01% | 2131 |
|
|
2014
Q2 | $111K | Buy |
8,437
+1,815
| +27% | +$22.9K | ﹤0.01% | 2088 |
|
|
2014
Q1 | $88K | Buy |
+6,622
| New | +$87.2K | ﹤0.01% | 2019 |
|
Other funds holding CDMO
Stifel Financial's CDMO Position: Q1 2025 in Review
Stifel Financial sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q1 2025, closing a stake of 16,512 shares — an estimated $204K sold.
Stifel Financial first reported a position in CDMO in Q1 2014 and held it in 30 quarters. The position peaked at $1.24M in Q3 2018. 2 funds tracked by Wall St. Rank hold CDMO as of Q1 2025.
- Stifel Financial reported no remaining Avid Bioservices, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
- Stifel Financial sold 16,512 Avid Bioservices, Inc. Common Stock shares in Q1 2025, an estimated $204K.
- Stifel Financial first reported a position in Avid Bioservices, Inc. Common Stock in Q1 2014 and held it in 30 quarters.
- Stifel Financial's Avid Bioservices, Inc. Common Stock position peaked at $1.24M in Q3 2018.
- 2 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q1 2025.
Based on Stifel Financial's 13F filing for Q1 2025, filed 14 May 2025.